148 related articles for article (PubMed ID: 24849765)
21. Connectivity of corticostriatal circuits in nonmanifesting LRRK2 G2385R and R1628P carriers.
Zhang D; Yao J; Ma J; Gao L; Sun J; Fang J; He H; Wu T
CNS Neurosci Ther; 2022 Dec; 28(12):2024-2031. PubMed ID: 35934920
[TBL] [Abstract][Full Text] [Related]
22. Relationship between LRRK2 R1628P polymorphism and Parkinson's disease in Asian populations.
Zhao H; Kong Z
Oncotarget; 2016 Jul; 7(30):46890-46898. PubMed ID: 27384489
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
[TBL] [Abstract][Full Text] [Related]
24. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
[TBL] [Abstract][Full Text] [Related]
25. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.
Zabetian CP; Yamamoto M; Lopez AN; Ujike H; Mata IF; Izumi Y; Kaji R; Maruyama H; Morino H; Oda M; Hutter CM; Edwards KL; Schellenberg GD; Tsuang DW; Yearout D; Larson EB; Kawakami H
Mov Disord; 2009 May; 24(7):1034-41. PubMed ID: 19343804
[TBL] [Abstract][Full Text] [Related]
26. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
Zhang Z; Burgunder JM; An X; Wu Y; Chen W; Zhang J; Wang Y; Xu Y; Gou Y; Yuan G; Mao X; Peng R
Mov Disord; 2009 Oct; 24(13):1902-5. PubMed ID: 19672984
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort.
Sadhukhan T; Vishal M; Das G; Sharma A; Mukhopadhyay A; Das SK; Ray K; Ray J
Dis Markers; 2012; 32(6):355-62. PubMed ID: 22684232
[TBL] [Abstract][Full Text] [Related]
28. LRRK2-associated Parkinson's disease patients have better stereopsis than idiopathic Parkinson disease.
Sun L; Chan P
Clin Neurol Neurosurg; 2018 Jun; 169():174-177. PubMed ID: 29705653
[TBL] [Abstract][Full Text] [Related]
29. The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation.
Rudenko IN; Kaganovich A; Hauser DN; Beylina A; Chia R; Ding J; Maric D; Jaffe H; Cookson MR
Biochem J; 2012 Aug; 446(1):99-111. PubMed ID: 22612223
[TBL] [Abstract][Full Text] [Related]
30. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence.
Tan EK; Tan LC; Lim HQ; Li R; Tang M; Yih Y; Pavanni R; Prakash KM; Fook-Chong S; Zhao Y
Hum Genet; 2008 Oct; 124(3):287-8. PubMed ID: 18781329
[TBL] [Abstract][Full Text] [Related]
31. Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus.
Garritano S; Gemignani F; Voegele C; Nguyen-Dumont T; Le Calvez-Kelm F; De Silva D; Lesueur F; Landi S; Tavtigian SV
BMC Genet; 2009 Feb; 10():5. PubMed ID: 19222838
[TBL] [Abstract][Full Text] [Related]
32. LRRK2 in Parkinson's disease: genetic and clinical studies from patients.
Kumari U; Tan EK
FEBS J; 2009 Nov; 276(22):6455-63. PubMed ID: 19804413
[TBL] [Abstract][Full Text] [Related]
33. Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.
Cao M; Gu ZQ; Li Y; Zhang H; Dan XJ; Cen SS; Li DW; Chan P
Neurosci Bull; 2016 Dec; 32(6):572-576. PubMed ID: 27699718
[TBL] [Abstract][Full Text] [Related]
34. Association of Parkinson's disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population.
Zhou Y; Luo X; Li F; Tian X; Zhu L; Yang Y; Ren Y; Pang H
J Clin Neurosci; 2012 Jul; 19(7):1011-5. PubMed ID: 22575062
[TBL] [Abstract][Full Text] [Related]
35. The LRRK2 R1628P variant plays a protective role in Han Chinese population with Alzheimer's disease.
Li HL; Lu SJ; Sun YM; Guo QH; Sadovnick AD; Wu ZY
CNS Neurosci Ther; 2013 Apr; 19(4):207-15. PubMed ID: 23421816
[TBL] [Abstract][Full Text] [Related]
36. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
[TBL] [Abstract][Full Text] [Related]
37. The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2.
Rudenko IN; Kaganovich A; Langston RG; Beilina A; Ndukwe K; Kumaran R; Dillman AA; Chia R; Cookson MR
Biochem J; 2017 Apr; 474(9):1547-1558. PubMed ID: 28320779
[TBL] [Abstract][Full Text] [Related]
38. LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.
Gao C; Pang H; Luo XG; Ren Y; Shang H; He ZY
J Neurol; 2013 Nov; 260(11):2884-9. PubMed ID: 24046064
[TBL] [Abstract][Full Text] [Related]
39. Penetrance of Parkinson disease LRRK2 G2385R-associated variant in the Chinese population.
Wang P; Cui P; Luo Q; Chen J; Tang H; Zhang L; Chen S; Ma J
Eur J Neurol; 2022 Sep; 29(9):2639-2644. PubMed ID: 35608967
[TBL] [Abstract][Full Text] [Related]
40. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
